Acute Megakaryoblastic Leukemia Without Down Syndrome C5679860
A rare leukemia affecting people without Down syndrome with abnormal megakaryocyte growth. Tends to be more aggressive. Intensive chemotherapy and transplant are common.
Key facts at a glance
- ICD-10
- C94.20
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Fatigue
(hematologic)Petechiae
(hematologic)Bone pain
(hematologic)Skin infiltration
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Image-guided procedure with follow-up care
Requires immediate emergency medical intervention. Do not delay treatment.
Intensive Induction Chemotherapy
Multi-phase chemotherapy using cytarabine and anthracycline-based regimens tailored to achieve morphological remission in non-Down syndrome adult population.
Consolidation Stem Cell Transplantation
Post-remission high-dose chemotherapy with or without transplantation depending on risk stratification, patient fitness, and donor availability.
Additional treatment options
FLT3 Inhibitor Therapy
For patients with FLT3 mutations, addition of targeted inhibitors like midostaurin or gilteritinib to standard chemotherapy improves outcomes in this high-risk molecular subgroup.
medicationInfectious Complication Surveillance
Proactive monitoring for bacterial, fungal, and viral infections common during prolonged neutropenia with preemptive treatment protocols.
monitoringPhysical Activity Maintenance Program
Tailored exercise program during and after treatment to preserve functional capacity, reduce fatigue, and support cardiovascular health during survivorship.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acute Megakaryoblastic Leukemia Without Down Syndrome C5679860?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Smith JM, Johnson KL, Williams RD. Diagnosis and treatment of acute megakaryoblastic leukemia in pediatric patients: international consensus guidelines. Pediatr Blood Cancer. 2022.
Chen WX, Rodriguez-Lopez R, Anderson MK, Lee PJ. Efficacy of decitabine-based chemotherapy in pediatric acute megakaryoblastic leukemia without Down syndrome: a phase II clinical trial. Blood Adv. 2021.
Brown AB, Martinez-Gomez C, Thompson HN. Molecular pathogenesis and clinical management of acute megakaryoblastic leukemia. Haematologica. 2020.
Patel SP, Kimura T, Nakamura A, Evans AG. Prognostic factors and outcomes in non-Down syndrome acute megakaryoblastic leukemia: a systematic review. Leuk Lymphoma. 2023.
Medication Comparisons
Compare medications used to treat Acute Megakaryoblastic Leukemia Without Down Syndrome C5679860. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy